Equities

Shanghai MicroPort Endovascular MedTech Group Co Ltd

688016:SHH

Shanghai MicroPort Endovascular MedTech Group Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)80.71
  • Today's Change-24.49 / -23.28%
  • Shares traded1.39m
  • 1 Year change-37.37%
  • Beta1.1723
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,9669761,243
Total Receivables, Net15414175
Total Inventory211156107
Prepaid expenses332134
Other current assets, total0.480.470.46
Total current assets3,3651,2941,459
Property, plant & equipment, net339229123
Goodwill, net------
Intangibles, net346270116
Long term investments122126--
Note receivable - long term------
Other long term assets19183.99
Total assets4,2461,9951,754
LIABILITIES
Accounts payable404225
Accrued expenses765854
Notes payable/short-term debt2.294.550
Current portion long-term debt/capital leases119.098.84
Other current liabilities, total1837375
Total current liabilities313187162
Total long term debt243237
Total debt384646
Deferred income tax------
Minority interest202428
Other liabilities, total463432
Total liabilities402276259
SHAREHOLDERS EQUITY
Common stock837272
Additional paid-in capital2,623835818
Retained earnings (accumulated deficit)1,137810604
Treasury stock - common------
Unrealized gain (loss)1.401.97--
Other equity, total0.200.02--
Total equity3,8441,7191,494
Total liabilities & shareholders' equity4,2461,9951,754
Total common shares outstanding123107107
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.